Connection

Patrick Flume to Aminopyridines

Back to Details
This is a "connection" page, showing publications Patrick Flume has written about Aminopyridines.
Patrick Flume
Connection Strength
1.162
Aminopyridines
  1. Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis. J Cyst Fibros. 2019 09; 18(5):737-742.
    View in: PubMed
    Score: 0.608
  2. The study of CFTR modulators in the very young. Lancet Respir Med. 2019 04; 7(4):287-289.
    View in: PubMed
    Score: 0.153
  3. Cystic Fibrosis: Translating Molecular Mechanisms into Effective Therapies. Ann Am Thorac Soc. 2018 08; 15(8):897-902.
    View in: PubMed
    Score: 0.148
  4. Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR. J Cyst Fibros. 2017 May; 16(3):371-379.
    View in: PubMed
    Score: 0.134
  5. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med. 2015 07 16; 373(3):220-31.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.